Healthcare Manifesto 2007

Towards Patient-Centred Healthcare Systems

www.healthcare-manifesto.org

Today European biotech industry leaders publish a new Healthcare Manifesto. More than 325 million patients to date have benefited from biotech medicines to treat or prevent heart attacks, Multiple Sclerosis, breast cancer, cystic fibrosis, leukaemia and other diseases including rare disorders. But many patients do not have access to treatments and many diseases are still untreated. The manifesto, published by EuropaBio sets out seven key policy principles, areas that will need to be addressed in order to handle the healthcare innovations expected over the next few years that will provide the answers to unmet medical needs. 

 

• Press release                                                                                                  
     

• Manifesto

• Speaker press conference profiles:

Andrea Rappagliosi, Chairman of EuropaBio Healthcare Council                                                                      
Profile

Alastair Kent, President of European Genetic Alliance Network
Profile

• Patient Alliances - Expectations for Industry ,

          by Alastair Kent

• What is healthcare Biotechnology           

• What is EuropaBio

For further information, contact:

Adeline Farrelly
Communications Director
Tel: +32 2 739 03 13
Mob: +32 475 93 17 24
Fax: +32 2 735 4960
e-mail: a.farrelly@europabio.org

Michael Leader
Director, Healthcare Council
Tel: +32 2 739 03 13
Mob: +32 496 85 04 68
Fax: +32 2 735 49 60
e-mail: m.leader@europabio.org

Stefanie Pingitzer 
EuropaBio's Healthcare Council Manager
Tel: +32 2 739 03 13
Mob: +32 476 46 66 88
Fax: +32 2 735 4960
e-mail: s.pingitzer@europabio.org

EuropaBio
Avenue de l'Armée 6
B-1040 Brussels, Belgium
website: http://www.europabio.org